Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults
NCT ID: NCT06537232
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
20 participants
INTERVENTIONAL
2024-09-04
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of a Nutritional Supplement on Nutrient Status and Quality of Life
NCT06332898
The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health
NCT06181214
A Pharmacokinetic Study of a Novel Nutritional Product on Healthy Men and Women
NCT06316700
The Effects of a Novel Nutritional Product on Nutrient Gaps and Gut Health in Active Adults
NCT06521424
A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.
NCT06283732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phlebotomy will be conducted at baseline, 30-day crossover, and 60-day follow-up to assess DNA methylation in peripheral blood mononuclear cells. Visceral and total body fat, stool microbiome composition, and actigraphy will also be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delayed supplementation
Participants will consume greens-based supplement for 30 days after living their normal lives (free-living) for 30 days.
Greens-based Supplement
Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.
Immediate supplementation
Participant will consume greens-based supplement for 30 days after which they will crossover into a free-living/non-supplementation setting for 30 days.
Greens-based Supplement
Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Greens-based Supplement
Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index \> 30 kg/m\^2
* Low habitual dark green leafy vegetable consumption
* Willing to adhere to study protocol and measures
* Willing to communicate via smartphone technology
* Able to read, write and speak English
Exclusion Criteria
* Diagnosis of a transient ischemic attack in the 6 months prior to screening
* Diagnosis of cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision
* Food allergies
50 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brickhouse Nutrition
UNKNOWN
Auburn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Fruge
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MIchael D Roberts, PhD
Role: PRINCIPAL_INVESTIGATOR
Auburn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Auburn University
Auburn, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUBHG 24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.